Company Overview

Update
Founded:
2012
Founders:
Madiha Derouazi
Headquarters:
1205 Geneva
Funding:
$0
Categories:
Biotechnology

Amal Therapeutics SA is a privately held Swiss/German biotech start-up company and spin-off from the University of Geneva.

Description

Update

Amal Therapeutics SA is a privately held Swiss/German biotech start-up company and spin-off from the University of Geneva. Amal Therapeutics was incorporated in September 2012. Amal uses its proprietary cell penetrating peptide platform to develop and progress therapeutic vaccines in oncology.

Current Team (1)

Update

Funding Rounds (1) - $0

Update

Investors (2)

Update

Offices/Locations (1)

Update
  • Office

    64 av.

    de la Roseraie

    1205 Geneva,

    ZAF

Images (1)

Update
  • 2779bf79f42ac6cb3116cbedcea7036d